Get Quotes

Market Menu

INCOME STATEMENTS-Aarey Drugs & Pharmaceuticals Ltd.

You can view the income statements for the last 5 years.

BSE

May 14
32.70 +1.30 (+ 4.14%)
Volume 337050
Prev. Close 31.40
Open Price 32.00
Today's Low / High
31.05
     
34.00
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
16.15
     
42.00
Aarey Drugs & Pharmaceuticals Ltd.is not traded in NSE
ISIN No INE198H01019 Market Cap. ( Rs. in Cr. ) 76.47 P/BV 0.83 Book Value ( Rs. ) 39.49
BSE Code 524412 52 Week High/Low ( Rs. ) 42/16 FV/ML 10/1 P/E(X) 13.20
NSE Code - Book Closure 30/09/2019 EPS ( Rs. ) 2.48 Div Yield (%) 0.00
( Rs. in Crs. )
ParticularsMar 20Mar 19Mar 18Mar 17Mar 16
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]300.09354.74349.35395.97246.03
Total Operating Revenues300.09354.74349.35395.97246.03
      
Other Income6.694.343.183.343.14
Total Revenue306.78359.08352.53399.30249.17
      
EXPENSES     
Purchase Of Stock-In Trade285.93347.45346.93386.12239.90
Operating And Direct Expenses0.000.000.000.001.03
Changes In Inventories Of FG,WIP And Stock-In Trade4.25-6.48-9.56-3.132.09
Employee Benefit Expenses0.400.470.380.340.26
Finance Costs1.792.231.924.331.72
Depreciation And Amortisation Expenses0.891.010.710.640.62
Other Expenses6.285.413.963.031.72
Total Expenses299.54350.09344.34391.33247.35
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax7.248.998.197.981.81
      
Profit/Loss Before Tax7.248.998.197.981.81
      
Tax Expenses-Continued Operations     
Current Tax1.502.252.252.100.52
Deferred Tax-0.050.19-0.240.410.00
Total Tax Expenses1.452.442.012.500.52
Profit/Loss After Tax And Before ExtraOrdinary Items5.796.546.185.471.29
      
Profit/Loss From Continuing Operations5.796.546.185.471.29
      
Profit/Loss For The Period5.796.546.185.471.29
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)2.482.802.643.030.77
Diluted EPS (Rs.)2.802.802.643.030.77
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.000.230.000.000.00
Equity Dividend Rate (%)0.001.000.000.000.00
ParticularsMar 20
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]300.09
Total Operating Revenues300.09
Other Income6.69
Total Revenue306.78
EXPENSES 
Purchase Of Stock-In Trade285.93
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade4.25
Employee Benefit Expenses0.40
Finance Costs1.79
Depreciation And Amortisation Expenses0.89
Other Expenses6.28
Total Expenses299.54
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax7.24
Profit/Loss Before Tax7.24
Tax Expenses-Continued Operations 
Current Tax1.50
Deferred Tax-0.05
Total Tax Expenses1.45
Profit/Loss After Tax And Before ExtraOrdinary Items5.79
Profit/Loss From Continuing Operations5.79
Profit/Loss For The Period5.79
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)2.48
Diluted EPS (Rs.)2.80
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.00
Equity Dividend Rate (%)0.00
s